Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Evofem Biosciences (EVFM) Change in Accured Expenses (2014 - 2026)

Updated

Evofem Biosciences (EVFM) posted Change in Accured Expenses of $600,000 for Q2 2026, down 56.0% from $1.36 million a year earlier.

Analysis

Evofem Biosciences (EVFM) Change in Accured Expenses (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Evofem Biosciences was $2.92 million, down 39.4% year-over-year; for FY2025, it was $4.47 million, down 15.7% from FY2024.

  • Annual Change in Accured Expenses shows a five-year compound annual growth rate of 9.5% (FY2020 to FY2025).
  • In prior years, Evofem Biosciences' Change in Accured Expenses was $5.3 million in FY2024 (+905.7%), $527,000 in FY2023, -$4.11 million in FY2022 and $5.47 million in FY2021 (+92.4%).
  • Quarterly Change in Accured Expenses has run from a low of -$3.46 million in Q4 2022 to a high of $3.45 million in Q4 2025 over five years.
  • On a year-over-year basis, Change in Accured Expenses increased in three of the last five quarters, with growth averaging 49.0%.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q2 2025, with growth of 291.7%; the weakest was Q1 2022, with a decline of 90.0%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$1.64 million (Q1 2026), $3.45 million (Q4 2025) and $502,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.41 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 1.20 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 338.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Evofem Biosciences 1.33 Mn 1.33 Mn 2.12 Mn 600,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 600,000.00
Mar 31, 2026 -1.64 Mn
Dec 31, 2025 3.45 Mn
Sep 30, 2025 502,000.00
Jun 30, 2025 1.36 Mn
Mar 31, 2025 -849,000.00
Dec 31, 2024 3.07 Mn
Sep 30, 2024 1.23 Mn
Jun 30, 2024 348,000.00
Mar 31, 2024 652,000.00
Dec 31, 2023 -1.11 Mn
Sep 30, 2023 792,000.00
Jun 30, 2023 1.64 Mn
Mar 31, 2023 -800,000.00
Dec 31, 2022 -3.46 Mn
Sep 30, 2022 1.28 Mn
Jun 30, 2022 -2.40 Mn
Mar 31, 2022 469,000.00
Dec 31, 2021 -525,000.00
Sep 30, 2021 1.99 Mn
API Access

Evofem Biosciences Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=EVFM&period=max&api_key=YOUR_API_KEY